TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 14989395

Group type: EXPERIMENTAL
Intervention: Fexofenadine, 180 mg once daily (10 PM)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Butterbur, 50 mg twice daily (8 AM and 10 PM)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Montelukast, 10 mg once daily (10 PM)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 11381380

Group type: EXPERIMENTAL
Intervention: Arthrocentesis plus intra-articular injection of sodium hyaluronate (SH)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Arthrocentesis alone
Number of subjects: 41
Study: 9216117

Group type: EXPERIMENTAL
Intervention: fenofibrate 100 mg tid
Number of subjects: 12

Group type: COMPARATOR
Intervention: gemfibrozil 600 mg bid
Number of subjects: 12
Study: 8256386

Group type: EXPERIMENTAL
Intervention: 2.3 ppm NO2
Number of subjects: 14

Group type: COMPARATOR
Intervention: Clean air
Number of subjects: 14
Study: 3311548

Group type: EXPERIMENTAL
Intervention: Ibuprofen 400 mg plus Codeine 60 mg
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Ibuprofen 200 mg plus Codeine 30 mg
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Ibuprofen 400 mg alone
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Codeine 60 mg alone
Number of subjects: 195

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 195
Study: 28443698

Group type: EXPERIMENTAL
Intervention: Maternal nutritional supplementation (MNS) 252 kcal/day daily up to 12 weeks postpartum and four breastfeeding education and support sessions
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: Maternal nutritional supplementation (MNS)
Number of subjects: 228

Group type: COMPARATOR
Intervention: Control (standards of care)
Number of subjects: 228
Study: 28025374

Group type: EXPERIMENTAL
Intervention: 0.2% ropivacaine
Number of subjects: 50

Group type: COMPARATOR
Intervention: 0.1% ropivacaine
Number of subjects: 50
Study: 25652604

Group type: EXPERIMENTAL
Intervention: Fludarabine plus 2 Gy total body irradiation (Flu-TBI arm; n=49)
Number of subjects: 94

Group type: COMPARATOR
Intervention: 8 Gy TLI + anti-thymocyte globulin (TLI-ATG arm; n=45)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Fludarabine plus 2 Gy total body irradiation (Flu-TBI arm)
Number of subjects: 94

Group type: COMPARATOR
Intervention: 8 Gy TLI + anti-thymocyte globulin (TLI-ATG arm)
Number of subjects: 94
Study: 23902874

Group type: EXPERIMENTAL
Intervention: Fulvestrant plus anastrozole (500 mg intramuscular injection on day 1, followed by 250 mg doses on days 15 and 29, and then every 28 days) plus daily oral anastrozole (1 mg)
Number of subjects: 723

Group type: COMPARATOR
Intervention: Fulvestrant plus placebo (fulvestrant 500 mg intramuscular injection on day 1, followed by 250 mg doses on days 15 and 29, and then every 28 days)
Number of subjects: 723

Group type: COMPARATOR
Intervention: Exemestane (25 mg daily oral)
Number of subjects: 723
Study: 21910898

Group type: EXPERIMENTAL
Intervention: 2 g of plant sterol esters daily in liquid yoghurt for 24 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo control (yogurt not supplemented with plant sterol esters)
Number of subjects: 0
Study: 18752381

Group type: EXPERIMENTAL
Intervention: Intervention group (pharmacists involved in care)
Number of subjects: 179

Group type: COMPARATOR
Intervention: Control group (usual care from physicians)
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 179

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 179
Study: 17058629

Group type: EXPERIMENTAL
Intervention: Ezetimibe 10 mg added to ongoing statin therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo plus statin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ezetimibe plus statin
Number of subjects: 0
Study: 12965106

Group type: EXPERIMENTAL
Intervention: nateglinide 120 mg
Number of subjects: 10

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 10
Study: 10930201

Group type: EXPERIMENTAL
Intervention: Oral clonidine premedication (5 microg x kg(‐1) 90 min before surgery)
Number of subjects: 41

Group type: COMPARATOR
Intervention: No clonidine (control group)
Number of subjects: 41
Study: 8737759

Group type: EXPERIMENTAL
Intervention: Nifedipine solution administered locally to the stomach
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Nifedipine solution administered locally to the small intestine
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Nifedipine solution administered locally to the colon (two sites)
Number of subjects: 4

Group type: COMPARATOR
Intervention: Intravenous infusion of nifedipine
Number of subjects: 4
Study: 1448588

Group type: EXPERIMENTAL
Intervention: Inspired CO2 increased to restore PETCO2 to normal
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Rate of fall of PCO2 protocols (0.1, 2.5, or 5 min)
Number of subjects: 9
Study: 6367691

Group type: EXPERIMENTAL
Intervention: Diazepam
Number of subjects: 21

Group type: COMPARATOR
Intervention: Propranolol
Number of subjects: 21
Study: 29659684

Group type: EXPERIMENTAL
Intervention: n‐3 (Ï‰‐3) fatty acids
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Shorter chain n‐3 fatty acids from plant sources and long‐chain n‐3 fatty acids from marine sources
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dietary assessments by questionnaires and circulating biomarkers
Number of subjects: 0
Study: 26915719

Group type: EXPERIMENTAL
Intervention: Advanced Practice Nurse‐led telehealth rehabilitative programme
Number of subjects: 172

Group type: COMPARATOR
Intervention: Standard follow‐up care
Number of subjects: 172
Study: 24117656

Group type: EXPERIMENTAL
Intervention: CWMT Active
Number of subjects: 85

Group type: COMPARATOR
Intervention: CWMT Placebo
Number of subjects: 85
Study: 22660026

Group type: EXPERIMENTAL
Intervention: IDegAsp
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: AF
Number of subjects: 182

Group type: COMPARATOR
Intervention: BIAsp 30
Number of subjects: 182
Study: 20669317

Group type: EXPERIMENTAL
Intervention: Pramipexole ER once daily
Number of subjects: 259

Group type: EXPERIMENTAL
Intervention: Pramipexole IR three times daily
Number of subjects: 259

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 259
Study: 17432541

Group type: EXPERIMENTAL
Intervention: Application of antioxidant and mitochondrial stimulating cream and oral administration of antioxidants and phenylalanine
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Application of antioxidant and mitochondrial stimulating cream
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo cream
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo AF (application of a placebo cream and oral administration of antioxidants and phenylalanine)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Without cream AF (oral administration of antioxidants and phenylalanine)
Number of subjects: 100
Study: 15710335

Group type: EXPERIMENTAL
Intervention: Conventional immunotherapy (n=7)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Short-term immunotherapy (n=7)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo (n=10)
Number of subjects: 24
Study: 11781125

Group type: EXPERIMENTAL
Intervention: Acupuncture (exact dosage and duration not specified)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Randomized trials
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Non-randomized studies
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Studies meeting more quality criteria (both randomized and non-randomized)
Number of subjects: 59
Study: 10520212

Group type: EXPERIMENTAL
Intervention: Methionine synthase D919G polymorphism (DD genotype)
Number of subjects: 607

Group type: EXPERIMENTAL
Intervention: Individuals with low B(6) levels
Number of subjects: 607

Group type: COMPARATOR
Intervention: Thermolabile MTHFR polymorphism
Number of subjects: 607
Study: 7554180

Group type: EXPERIMENTAL
Intervention: STAR (10 mg given intravenously over 30 minutes)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: STAR (20 mg given intravenously over 30 minutes)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Accelerated RTPA (recombinant tissue-type plasminogen activator) over 90 minutes
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: STAR
Number of subjects: 100

Group type: COMPARATOR
Intervention: Accelerated RTPA
Number of subjects: 100
Study: 1983493

Group type: EXPERIMENTAL
Intervention: Postoperative treatment modalities including ventilation, deflation of the interponate, and special dietary plan
Number of subjects: 0
Study: 427400

Group type: EXPERIMENTAL
Intervention: Intensive rehabilitation
Number of subjects: 143

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 143
Study: 29319747

Group type: EXPERIMENTAL
Intervention: Orientation group with nursing consultations and group meetings
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control group with only nursing consultations
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Orientation group
Number of subjects: 27
Study: 26921161

Group type: EXPERIMENTAL
Intervention: Video intervention (5-minute organ donation video on iPads)
Number of subjects: 915

Group type: COMPARATOR
Intervention: Control (usual routine visit)
Number of subjects: 915

Group type: EXPERIMENTAL
Intervention: Intervention (5-minute organ donation video on iPads)
Number of subjects: 915
Study: 25511688

Group type: EXPERIMENTAL
Intervention: Kinesiology taping applied on the affected side using the muscle-relaxing technique
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control group (no kinesiology taping)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Kinesiology taping applied on healthy infants
Number of subjects: 29
Study: 23835510

Group type: EXPERIMENTAL
Intervention: Rilpivirine (RPV) + FTC/TDF
Number of subjects: 1096

Group type: COMPARATOR
Intervention: Efavirenz (EFV) + FTC/TDF
Number of subjects: 1096
Study: 20533765

Group type: EXPERIMENTAL
Intervention: Valacyclovir 250 mg
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Valacyclovir 1000 mg
Number of subjects: 82
Study: 19122337

Group type: EXPERIMENTAL
Intervention: Pranlukast 225 mg single dose
Number of subjects: 16

Group type: COMPARATOR
Intervention: Clarithromycin 200 mg twice daily for 7 days + Pranlukast 225 mg single dose on day 7
Number of subjects: 16
Study: 16618015

Group type: EXPERIMENTAL
Intervention: PRO 160/120 (2 x 1 capsule/d)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Tamsulosin (1 x 0.4 mg/d)
Number of subjects: 140
Study: 11684627

Group type: EXPERIMENTAL
Intervention: B9340 (bradykinin receptor antagonist)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 9699089

Group type: EXPERIMENTAL
Intervention: Lispro
Number of subjects: 24

Group type: COMPARATOR
Intervention: U40 regular insulin
Number of subjects: 24

Group type: COMPARATOR
Intervention: U100 regular insulin at 8 degrees C
Number of subjects: 24

Group type: COMPARATOR
Intervention: U100 regular insulin at 37 degrees C
Number of subjects: 24
Study: 7733610

Group type: EXPERIMENTAL
Intervention: Preoperative ultrasound (US) localization of abnormal parathyroid glands
Number of subjects: 28

Group type: COMPARATOR
Intervention: No preoperative ultrasound (US) localization
Number of subjects: 28
Study: 2689469

Group type: COMPARATOR
Intervention: Verapamil-SR 60 mg
Number of subjects: 221

Group type: COMPARATOR
Intervention: Verapamil-SR 120 mg
Number of subjects: 221
Study: 8134676

Group type: EXPERIMENTAL
Intervention: Propofol (1% infusion at 6 mg/kg/h for 10 minutes, then 3 mg/kg/h)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Midazolam (0.3% infusion with initial bolus of 0.06 mg/kg and infusion at 0.05 mg/kg/h)
Number of subjects: 40
Study: 226725

Group type: EXPERIMENTAL
Intervention: Metronidazole and Oxytetracycline
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Di-iodohydroxyquinoline and Oxytetracycline
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Di-iodohydroxyquinoline, Oxytetracycline, and Dehydroemetine
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Clioquinol and Oxytetracycline
Number of subjects: 300
Study: 31188681

Group type: EXPERIMENTAL
Intervention: Hyperoxic preconditioning (pure oxygen for 5 minutes prior to exercise)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Nonhyperoxic preconditioning (chamber air for 5 minutes prior to exercise)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Hyperoxic preconditioning
Number of subjects: 17
Study: 30444838

Group type: EXPERIMENTAL
Intervention: Intensive treatment (target SBP < 120 mmHg)
Number of subjects: 9068

Group type: COMPARATOR
Intervention: Standard treatment (target SBP between 135 and 139 mmHg)
Number of subjects: 9068
Study: 28401876

Group type: EXPERIMENTAL
Intervention: ABC/DTG/3TC (early-switch group)
Number of subjects: 553

Group type: COMPARATOR
Intervention: Current ART (late-switch group)
Number of subjects: 553

Group type: EXPERIMENTAL
Intervention: ABC/DTG/3TC
Number of subjects: 553

Group type: COMPARATOR
Intervention: Current ART
Number of subjects: 553

Group type: COMPARATOR
Intervention: Late-switch group (post-switch)
Number of subjects: 553
Study: 26073022

Group type: EXPERIMENTAL
Intervention: MK-7 treated group (n=42)
Number of subjects: 84

Group type: COMPARATOR
Intervention: MK-7 naïve group (n=42)
Number of subjects: 84
Study: 24125483

Group type: EXPERIMENTAL
Intervention: Spironolactone 50 mg daily for 6 weeks
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo for 6 weeks
Number of subjects: 32
Study: 21193178

Group type: EXPERIMENTAL
Intervention: Binge Eating Disorder (BED) group (n = 40)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Non-binge-eating control group (n = 39)
Number of subjects: 79
Study: 19106380

Group type: EXPERIMENTAL
Intervention: Insulin glargine
Number of subjects: 90

Group type: COMPARATOR
Intervention: NPH/Lente insulin
Number of subjects: 90
Study: 17300298

Group type: EXPERIMENTAL
Intervention: Head flexion position
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Neutral head position
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Head extension position
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Comparison of flexion and neutral positions between genders
Number of subjects: 102
Study: 15133820

Group type: EXPERIMENTAL
Intervention: Naloxone (non-subtype-selective opioid receptor antagonist)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 12825763

Group type: EXPERIMENTAL
Intervention: Cervical traction plus exercise
Number of subjects: 199

Group type: COMPARATOR
Intervention: Non-steroidal anti-inflammatory drug (NSAID)
Number of subjects: 199
Study: 9808908

Group type: EXPERIMENTAL
Intervention: Serum level of copper
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Serum level of ceruloplasmin
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Copper and ceruloplasmin levels
Number of subjects: 40
Study: 7667832

Group type: COMPARATOR
Intervention: Low-dose estrogen (0.625 mg conjugated estrogens)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Oral contraceptives (30-50 micrograms ethinyl estradiol daily)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: High-dose estrogen (300 micrograms ethinyl estradiol daily)
Number of subjects: 83
Study: 2654329

Group type: EXPERIMENTAL
Intervention: C + M (methotrexate 50 mg/m2 on days 1 and 15 plus cisplatin 80 mg/m2 on day 2 every 4 weeks)
Number of subjects: 108

Group type: COMPARATOR
Intervention: C (cisplatin 80 mg/m2 on day 1 every 4 weeks)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: C + M
Number of subjects: 108

Group type: COMPARATOR
Intervention: C
Number of subjects: 108
Study: 11425

Group type: EXPERIMENTAL
Intervention: Parsalmide
Number of subjects: 16

Group type: COMPARATOR
Intervention: Diazepam
Number of subjects: 16
Study: 31361934

Group type: EXPERIMENTAL
Intervention: Intralesional bleomycin
Number of subjects: 164

Group type: COMPARATOR
Intervention: Intralesional triamcinolone
Number of subjects: 164
Study: 28279941

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy + trastuzumab in HER2-positive cases
Number of subjects: 340

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy + celecoxib in HER2-negative cases
Number of subjects: 340

Group type: COMPARATOR
Intervention: Adjuvant trastuzumab
Number of subjects: 340
Study: 26348402

Group type: EXPERIMENTAL
Intervention: Euvichol
Number of subjects: 1263

Group type: COMPARATOR
Intervention: Shanchol
Number of subjects: 1263
Study: 23512444

Group type: EXPERIMENTAL
Intervention: Prophylactic sheet of polypropylene mesh fixed in the preperitoneal space during wound closure (Group I)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Conventional wound closure (Group II)
Number of subjects: 64
Study: 21671456

Group type: COMPARATOR
Intervention: Nabiximols 10.8 mg
Number of subjects: 23

Group type: COMPARATOR
Intervention: Nabiximols 21.6 mg
Number of subjects: 23

Group type: COMPARATOR
Intervention: Nabiximols 43.2 mg
Number of subjects: 23

Group type: COMPARATOR
Intervention: Dronabinol 20 mg
Number of subjects: 23

Group type: COMPARATOR
Intervention: Dronabinol 40 mg
Number of subjects: 23

Group type: COMPARATOR
Intervention: Dronabinol (combined with placebo)
Number of subjects: 23
Study: 19266699

Group type: EXPERIMENTAL
Intervention: REVEAL Impact of Genetic Testing for Alzheimer's disease (IGT‐AD) scale
Number of subjects: 276
Study: 17681164

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 147

Group type: COMPARATOR
Intervention: Psychoeducation
Number of subjects: 147

Group type: COMPARATOR
Intervention: Wait list
Number of subjects: 147
Study: 15492789

Group type: EXPERIMENTAL
Intervention: C1772T polymorphism in HIF‐1alpha gene in colorectal cancer patients
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (healthy subjects)
Number of subjects: 200
Study: 11480500

Group type: EXPERIMENTAL
Intervention: Dietary antioxidants (400 IU vitamin E/500 mg vitamin C)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo (air exposure)
Number of subjects: 17
Study: 9972066

Group type: EXPERIMENTAL
Intervention: Nitroblue tetrazolium test (NBT) after renal artery embolization
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Granulocyte stimulation in vitro by LPS of E. coli
Number of subjects: 45
Study: 8049437

Group type: EXPERIMENTAL
Intervention: Standard or high-dose Ara-C together with daunorubicin and etoposide as induction chemotherapy
Number of subjects: 168
Study: 3288477

Group type: EXPERIMENTAL
Intervention: Bromocriptine
Number of subjects: 0

Group type: COMPARATOR
Intervention: L-dopa (as Sinemet)
Number of subjects: 0
Study: 30131049

Group type: EXPERIMENTAL
Intervention: Evening ramipril and morning indapamide retard + evening amlodipine (subgroup 1A and 2A)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Morning ramipril + evening indapamide-retard and amlodipine (subgroup 1B and 2B)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Treatment irrespective of salt sensitivity and dosing regimen
Number of subjects: 130
Study: 27428108

Group type: EXPERIMENTAL
Intervention: Complementary Therapies for Labour and Birth (CTLB) protocol, which includes acupressure, relaxation, visualisation, breathing, massage, yoga techniques, and facilitated partner support, attended a two-day antenatal education programme plus standard care.
Number of subjects: 32

Group type: COMPARATOR
Intervention: Standard care alone (control group).
Number of subjects: 32
Study: 25641464

Group type: EXPERIMENTAL
Intervention: Quick Prostate Test (QPT)
Number of subjects: 64

Group type: COMPARATOR
Intervention: IPSS‐Q8
Number of subjects: 64
Study: 24036775

Group type: EXPERIMENTAL
Intervention: Piezosurgery
Number of subjects: 110

Group type: COMPARATOR
Intervention: Conventional osteotomy (Control)
Number of subjects: 110
Study: 20737384

Group type: EXPERIMENTAL
Intervention: Warm tumescence fluid (37 degrees C)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Cold tumescence fluid (5 degrees C)
Number of subjects: 85
Study: 19052245

Group type: EXPERIMENTAL
Intervention: Assessments of physical function with feedback to the participant and the participant's family physician
Number of subjects: 265

Group type: COMPARATOR
Intervention: Functional assessments alone
Number of subjects: 265
Study: 15679556

Group type: EXPERIMENTAL
Intervention: Supervised treatment with sulfadoxine/pyrimethamine and artesunate
Number of subjects: 169

Group type: COMPARATOR
Intervention: Unsupervised treatment with sulfadoxine/pyrimethamine and artesunate
Number of subjects: 169
Study: 12692009

Group type: EXPERIMENTAL
Intervention: TNF-alpha
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 10589887

Group type: EXPERIMENTAL
Intervention: Daily trimethoprim-sulfamethoxazole (160 mg/800 mg)
Number of subjects: 2625

Group type: COMPARATOR
Intervention: Thrice-weekly trimethoprim-sulfamethoxazole (160 mg/800 mg)
Number of subjects: 2625
Study: 7852106

Group type: EXPERIMENTAL
Intervention: Twice-daily radiation therapy (RT) at 1.2 Gy BID (64.8 Gy, 72.0 Gy, 76.8 Gy, 81.6 Gy)
Number of subjects: 786

Group type: EXPERIMENTAL
Intervention: Accelerated hyperfractionated RT at 1.6 Gy BID (48.0 Gy, 54.4 Gy)
Number of subjects: 786

Group type: EXPERIMENTAL
Intervention: 72.0 Gy arm
Number of subjects: 786

Group type: COMPARATOR
Intervention: Age and Karnofsky Performance Scores (KPS)
Number of subjects: 786
Study: 2045613

Group type: EXPERIMENTAL
Intervention: Atropine (4 mg/ml) inhaled for 5 minutes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fenoterol (0.4 mg/ml) inhaled for 5 minutes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aminophylline (250 mg) intravenous injection
Number of subjects: 0
Study: 6173993

Group type: EXPERIMENTAL
Intervention: Phlebotomy therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low-dose chloroquine treatment
Number of subjects: 0
Study: 31953634

Group type: EXPERIMENTAL
Intervention: 40 mg pantoprazole per day for 3 months
Number of subjects: 60

Group type: COMPARATOR
Intervention: No PPI therapy
Number of subjects: 60
Study: 31538599

Group type: EXPERIMENTAL
Intervention: Suvorexant 10 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Suvorexant 20 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 29560910

Group type: EXPERIMENTAL
Intervention: Acute stress
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control procedure
Number of subjects: 25
Study: 27273347

Group type: EXPERIMENTAL
Intervention: Polyphenol-rich beverage
Number of subjects: 103

Group type: COMPARATOR
Intervention: Beverage without polyphenols (Control)
Number of subjects: 103
Study: 24106324

Group type: EXPERIMENTAL
Intervention: Expiratory rib cage compression (ERCC)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (CTRL)
Number of subjects: 20
Study: 23767862

Group type: EXPERIMENTAL
Intervention: 400 mg of herbal blend twice daily
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100